Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells

Rupali R Hire1,2, Shalini Srivastava1, Melissa B Davis2

  • 1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, 400076 India.

Scientific Reports
|March 25, 2017
PubMed

Insights

Crocin, a saffron component, inhibits cancer cell proliferation by targeting and disrupting microtubules. This natural compound interferes with cell division, offering potential as an anticancer therapeutic agent.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Crocin, derived from saffron, exhibits known anticancer properties.
  • The specific molecular targets and mechanisms of crocin's anticancer activity remain largely unelucidated.

Purpose of the Study:

  • To identify the molecular targets of crocin's anticancer effects.
  • To investigate how crocin affects cancer cell proliferation at the cellular and molecular level.

Main Methods:

  • Cell proliferation assays using multiple cancer cell lines (HCC70, HCC1806, HeLa, CCD1059sk).
  • Microtubule depolymerization and spindle formation analysis.
  • In vitro tubulin assembly assays and electron microscopy.
  • Biochemical assays to determine crocin-tubulin binding site.

Main Results:

  • Crocin inhibited the proliferation of various cancer cell lines.
  • Crocin depolymerized interphase and mitotic microtubules, induced multipolar spindles, and inhibited mitosis.
  • In vitro studies demonstrated crocin's inhibition of tubulin assembly and induction of tubulin aggregation.
  • Crocin binds to tubulin at the vinblastine-binding site, suggesting a direct interaction.

Conclusions:

  • Crocin inhibits cancer cell proliferation primarily by disrupting the microtubule network.
  • The findings identify tubulin as a key molecular target of crocin.
  • Crocin's mechanism of action involves interference with microtubule dynamics and cell division.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K